课题基金 / 基金详情

PHASE I STUDY OF BMS188667 IN PSORIASIS VULGARIS

PHASE I STUDY OF BMS188667 IN PSORIASIS VULGARIS
BMS188667 治疗寻常型银屑病的 I 期研究
批准号:
6113244
负责人:
CYNTHIA GUZZO
金额:
$2.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

CYNTHIA GUZZO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This was a multi-center, open-label, dose escalation Phase I trial designed to test the safety, pharmacokinetics, and preliminary biologic activity of BMS-188667 (CTLA4Ig) administered as four intravenous injections on Days 1, 3, 16, and 29 to patients with psoriasis vulgaris. The major goals of this study were the determination of: the safety, pharmacokinetics, immunogenicity, and recovery time from biological effects and optimal biologic dose for psoriasis treatment of Bms-188667.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY, TOLERABILITY, AND BIOLOGIC ACTIVITY OF L 733,723 IN PSORIATIC PATIENTS
  • 批准号:
    6274493
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    1998
  • 负责人:
    CYNTHIA GUZZO
  • 依托单位:
TOLERABILITY/PHARMACOKINETICS OF DAB389 IL 2 IN PATIENTS WITH SEVERE PSORIASIS
  • 批准号:
    6274518
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    1998
  • 负责人:
    CYNTHIA GUZZO
  • 依托单位:
BMS 188667 (CTLA4KG) IN PATIENTS WITH PSORIASIS VULGARIS
  • 批准号:
    6274552
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    1998
  • 负责人:
    CYNTHIA GUZZO
  • 依托单位:
DOSE ESCALATION STUDY OF MEDI 507, HUMANIZED MONOCLONAL ANTIBODY CD2
  • 批准号:
    6263605
  • 项目类别:
  • 资助金额:
    $2.51万
  • 财政年份:
    1998
  • 负责人:
    CYNTHIA GUZZO
  • 依托单位:
海外基金